Detalles de la búsqueda
1.
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
N Engl J Med
; 385(16): 1485-1495, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34644472
2.
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.
Br J Clin Pharmacol
; 83(11): 2386-2397, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28662542
3.
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Lancet
; 386(9991): 360-8, 2015 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26026936
4.
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.
Nat Commun
; 15(1): 4081, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744844
5.
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.
J Peripher Nerv Syst
; 22(2): 149-152, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28594116
6.
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.
Eur Heart J
; 31(18): 2271-9, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20601389
7.
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Circulation
; 119(14): 1883-91, 2009 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19332468
8.
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
Pharmacogenet Genomics
; 20(2): 77-85, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20065889
9.
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
Blood Press
; 18(6): 348-61, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20001655
10.
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Ann Intern Med
; 147(5): 311-9, 2007 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-17785486
11.
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Circulation
; 113(12): 1588-96, 2006 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16534012
12.
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
Lancet Respir Med
; 5(1): 51-60, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27916480
13.
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
J Am Coll Cardiol
; 46(5): 770-5, 2005 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-16139123
14.
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
JAMA
; 296(10): 1242-8, 2006 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-16968848
15.
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials.
Chronic Obstr Pulm Dis
; 4(1): 34-44, 2016 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848909
16.
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Circulation
; 110(11): 1456-62, 2004 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-15326072
17.
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Circulation
; 108(6): 684-90, 2003 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-12885747
18.
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
Lancet
; 362(9384): 619-20, 2003 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-12944063
19.
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.
J Am Coll Cardiol
; 43(6): 1047-55, 2004 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-15028365
20.
Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Am J Med
; 118(6): 649-57, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15922697